English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

In Alzheimer’s disease (AD), white matter (WM) degeneration begins early, increases with disease progression, and contributes to cognitive impairment, yet the mechanisms are poorly understood. This article reviews the roles of myelin loss, oligodendrocyte dysfunction, and microvasculopathy in relation to AD WM degeneration. Myelin loss impairs axonal function and its breakdown promotes oxidative stress, inflammation, and lipid peroxidation, further compromising the structure and function of axons. Oligodendrocyte dysfunction impairs homeostatic mechanisms needed to maintain myelin. Microvascular disease with endothelial cell pathology leads to thrombin activation and pro-inflammatory cytokine release, oxidative stress, and increased vascular permeability. Progressive fibrotic replacement of smooth muscle cells reduces vaso-responsiveness to metabolic demands. Fibrotic thickening of vessel walls narrows the lumens, rendering them more susceptible to occlusion, endothelial cell injury, and thrombin activation. Since normal physiological functions of oligodendrocytes and microvascular endothelial cells rely on intact insulin/insulin-like growth factor (IGF) signaling through cell survival, metabolic and anti-inflammatory pathways, conceivably, WM degeneration in AD is mediated by insulin and IGF resistance with attendant pathogenic targeting of oligodendroglia and endothelial cells. The apolipoprotein E-e4 genotype may serve as a co-factor in AD associated glial-vascular WM degeneration due to its role as a mediator of insulin resistance.

Insulin Resistance and Oligodendrocyte/Microvascular Endothelial Cell Dysfunction as Mediators of White Matter Degeneration in Alzheimer’s Disease